About PhRMA
The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research companies, which are laser focused on developing innovative medicines that transform lives and create a healthier world. Together, we are fighting for solutions to ensure patients can access and afford medicines that prevent, treat and cure disease. Over the last decade, PhRMA member companies have invested more than $850 billion in the search for new treatments and cures, and they support nearly five million jobs in the United States.
Connect with PhRMA
For information on how innovative medicines save lives, please visit:
www.PhRMA.org
www.VotersforCures.org
www.AmericasMedicines.com
www.Facebook.com/PhRMA
www.X.com/PhRMA
America’s biopharmaceutical research ecosystem is the global leader in the development of innovative medicines, allowing patients in the U.S. to access new medicines faster than the rest of the world. This is the result of a carefully balanced policy environment that includes robust intellectual property (IP) protections that foster investment in groundbreaking research and development (R&D), while also promoting access for patients and the sustainability of the U.S. health care system. Here are the real facts about how patents help drive innovation and access, contrary to what some claim.
Debunking the False Narrative About Biopharmaceutical Patents image
Fact Sheet
Intellectual Property
Debunking the False Narrative About Biopharmaceutical Patents
Debunking the False Narrative About Biopharmaceutical Patents image